Clinical Trials Logo

Diabetes Mellitus, Type 2 clinical trials

View clinical trials related to Diabetes Mellitus, Type 2.

Filter by:

NCT ID: NCT05103306 Active, not recruiting - Clinical trials for Diabetes Mellitus, Type 2

Empagliflozin-based Quadruple Therapy vs Basal Insulin-based Therapy

LUCID
Start date: January 2017
Phase:
Study type: Observational [Patient Registry]

This study aimed to evaluate the long-term effectiveness and safety of the empagliflozin as add-on thearpy compared to basal insulin-based antidiabetic agents (OADs) combination therapy in patients with type 2 diabetes inadequately controlled on triple OADs in a real clinical practice.

NCT ID: NCT05102071 Withdrawn - Clinical trials for Diabetes Mellitus, Type 2

Clinical Outcomes and Healthcare Cost and Resource Utilization (HCRU) in Patients With Type 2 Diabetes and Cardiovascular Disease on 2nd Line Empagliflozin Versus 2nd Line Sulfonylureas

Start date: November 1, 2021
Phase:
Study type: Observational

Evaluation of clinical outcomes (specifically cardiovascular outcomes like hospitalization for heart failure), and healthcare cost, and resource utilization, among patients on empagliflozin as an add-on therapy to metformin versus patients on sulfonylureas as an add-on therapy to metformin in patients with Type 2 Diabetes (T2D) and Cardiovascular Disease (CVD).

NCT ID: NCT05101330 Withdrawn - Hypertension Clinical Trials

Impact of Bilingual Prescription Medication Labels Among Elderly Singaporeans

Start date: November 1, 2021
Phase: N/A
Study type: Interventional

The proposed study aims to provide preliminary data that will enable the conduct of a larger Randomized Controlled Trial (RCT) on the impact of bilingual Prescription Medication Labels (PMLs) on 3 medication-related outcomes - medication adherence, medication management self-efficacy, and PML understanding.

NCT ID: NCT05100576 Recruiting - Diabetes Clinical Trials

Intensified Insulin Therapy With Telemedicine

Start date: July 1, 2021
Phase: N/A
Study type: Interventional

Investigation of the effect of a 3-month telemedicine-led lifestyle intervention in individuals requiring intensified insulin therapy.

NCT ID: NCT05099367 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

Prostacyclin (PGI2) Pathway to Enhance Wound Healing in Diabetic Foot Ulcers

PGI2HEAL
Start date: October 1, 2021
Phase: N/A
Study type: Interventional

Prospective, monocentric, pathophysiological study, comparing 3 parallel groups: healthy controls; patients with diabetes and without DFU; patients with diabetes and with DFU. To address secondary objectives, samples from a fourth group will be collected.

NCT ID: NCT05099198 Completed - Diabetes Clinical Trials

Replication of the GRADE Diabetes Trial in Healthcare Claims Data

Start date: September 1, 2018
Phase:
Study type: Observational

Investigators are building an empirical evidence base for real world data through large-scale replication of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.

NCT ID: NCT05098600 Completed - Clinical trials for Rheumatoid Arthritis

The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic

Start date: October 15, 2021
Phase:
Study type: Observational

The study series consists of three studies with the aim to assess the incidence, prevalence, risk factors, comorbidities and management of patients with alopecia areata in Czech Republic based on the patients and registry of a dermatology clinic of a metropolitan hospital.

NCT ID: NCT05098327 Withdrawn - Prostate Cancer Clinical Trials

Pioglitazone and Insulin Resistance in ADT

Start date: August 1, 2021
Phase: Phase 3
Study type: Interventional

This study is being done to establish the mechanisms underlying insulin resistance (reduced insulin action that can lead to high blood sugar and maybe diabetes) in patients undergoing androgen deprivation therapy (ADT) for prostate carcinoma as well as to investigate the role of pioglitazone therapy in reduction/ reversal of that insulin resistance

NCT ID: NCT05098301 Completed - Diabetes Clinical Trials

Data Therapy Collection to Evaluate Performances of an Automated Insulin Titration Algorithm Compared to Standard Method of Titration

GLUCAL3
Start date: November 30, 2021
Phase:
Study type: Observational

A data collection of blood glucose values, insulin, meal composition will be performed for a period of two months, to evaluate the performances of an automated insulin titration algorithm

NCT ID: NCT05097534 Enrolling by invitation - Clinical trials for Diabetes Mellitus, Type 2

A Comprehensive Community Approach for Diabetes Prevention and Care for a Vulnerable Population in Galveston

Start date: December 7, 2021
Phase: N/A
Study type: Interventional

To improve diabetes self-management outcomes, patients with type 2 diabetes (n=150 - aged 13-84) recruited from St. Vincent Clinic (SVC) and Teen Health Center Inc., Clinics will be randomized using block randomization to receive standard of care or the integrated model. Patients in the intervention arm will be assessed for social and physical needs before being enrolled in a year-long education program (iDSMES). Enrollees will receive dietary counseling, physical and occupational therapy, in addition to other mental, financial and social benefits counseling. The investigators will compare the intervention outcomes.